MORGAN STANLEY PLC/CALL/TEVA PHARMACEUTICAL INDUSTRIES/20/1/20.12.24

MORGAN STANLEY PLC/CALL/TEVA PHARMACEUTICAL INDUSTRIES/20/1/20.12.24 Stock

DE000ME8VA23

Real-time Bid/Ask 12:07:35 2024-06-04 pm EDT
0.96 ^EUR / 0.97 ^EUR	-6.31%

Current month	+6.19%
1 month	+123.91%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart TEVA PHARMACEUTICAL INDUSTRIES LIMITED

Chart MORGAN STANLEY PLC/CALL/TEVA PHARMACEUTICAL INDUSTRIES/20/1/20.12.24

Latest news about TEVA PHARMACEUTICAL INDUSTRIES LIMITED

Teva Pharmaceuticals - New Data Provide Schizophrenia Treatment Insights into Switching to UZEDY Extended-Release Injectable Suspension from Invega Sustenna	Jun. 03	AQ
New Data Provide Schizophrenia Treatment Insights into Switching to UZEDY® (risperidone) Extended-Release Injectable Suspension from Invega Sustenna® (paliperidone palmitate)	Jun. 01	BU
Teva Presents First Real-World Data from the IMPACT-TD Registry Study at Psych Congress Elevate 2024	Jun. 01	BU
Teva Pharmaceutical Gains FDA Approval for Daily Huntington's Disease Pill	May. 30	MT

More news

Quotes 5-day view

Date	Price	Change
24-06-04	0.96	-6.80%
24-06-03	1.03	+6.19%
24-05-31	0.97	+6.59%
24-05-30	0.91	+8.33%
24-05-29	0.84	+1.20%

Delayed Quote Börse Stuttgart

Last update June 04, 2024 at 11:50 am EDT

More quotes

Static data

Product type	Warrant Plain-Vanilla
Buy / Sell	CALL
Underlying	TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Issuer	Morgan Stanley
WKN	ME8VA2
ISIN	DE000ME8VA23
Date issued	2024-02-16
Strike	20 $
Maturity	2024-12-20 (199 Days)
Parity	1 : 1
Emission price	0.37 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	1.1 €
Lowest since issue	0.189 €
Spread	0.01 €
Spread %	1.02%

Company Profile

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.

Sector

More about the company

Ratings for Teva Pharmaceutical Industries Limited

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Consensus: Teva Pharmaceutical Industries Limited

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

16.98 USD

Average target price

17.71 USD

Spread / Average Target

+4.28%

Consensus